Bull, Bear & Beyond by Edison Group

Polar Capital Global Healthcare Trust (PCGH) is a London-listed investment trust focused on the global healthcare sector. It is benchmarked against the MSCI All Country World Index and the MSCI World Health Care Index. The investment team was established in 2007 and includes fund managers who previously held senior roles in the healthcare industry before managing money in the sector. The trust tak...

Edison recently published a note on Murray Income Trust ************************************************************************************** About ‘Bull, Bear & Beyond’ Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second...

In this interview, we are joined by the CEO of Quadrise, Jason Miles, who discusses the recent signing of the Project Agreement with MSC and Cargill. Quadrise is an innovator and global supplier of emulsion technology that produces a synthetic, enhanced fuel oil called MSAR and a new biofuel called bioMSAR. The technology provides lower-cost and cleaner energy solutions for the marine, power and i...

Sareum Holdings (AIM: SAR) is a UK-listed drug-discovery company focused on the development of small molecule kinase inhibitors. Its in-house programmes are dual TYK2/JAK1 inhibitors: SDC-1801 for autoimmune diseases and SDC-1802 for cancer. The third development programme is SRA737, a CHK1 inhibitor targeting the DNA damage response network for the treatment of solid tumours. Sareum holds a 27.5%...

Recce Pharmaceuticals is an innovative, clinical-stage Australian company developing novel, broad-spectrum synthetic polymer anti-infective drugs for the treatment of several infectious diseases including sepsis, complex urinary tract infections, diabetic foot infections and other bacterial skin and skin structure infections. ************************************************************************...

VEON Group’s CFO, Joop Brakenhoff, discusses key financial structures and disciplines deployed by group management to drive success across the markets in which VEON operates. These include VEON’s capital allocation structure, commercial pricing strategy and its asset-light model. He also discusses how VEON is adapting to the rapid growth in digital services from a financial perspective and the gro...

"In this interview, VEON Group’s CEO, Kaan Terzioğlu, highlights the strategy, challenges and opportunities for VEON as it continues to penetrate its core markets in the Ukraine, Bangladesh and Pakistan. Kaan emphasises that VEON’s target is to expand into digital services, with offerings in adjacent sectors such as fintech, education, healthcare and entertainment, underpinned by VEON’s commitment...

In this interview, we speak to Jaco Prinsloo, CEO of Sylvania Platinum, the AIM-listed, South African-based platinum group metals (PGM) tailings dump retreatment company and soon-to-be chromite producer. He provides detail on recent production achievements from the Sylvania Dump Operations, comprising six chrome beneficiation and PGM processing plants, and an update on the transformational 50/50 T...

Edison’s investment companies team recently published a CGI review. The company has an enviable record of outperformance versus the Canadian market; 1.4 and 2.3pp per annum over the last 25 and 50 years respectively. While CGI offers a one-stop shop for investment in Canada, up to 25% of the portfolio may be invested in US stocks. Manager Greg Eckel is unconstrained by the benchmark’s sector weigh...

Edison’s investment companies team recently published a UIL review. In early October, the company announced plans to go private after the redemption of its 2028 zero dividend preference shares. UIL’s board has decided that despite the company holding some potentially exciting opportunities including the recently merged Waverton Investment Management and London & Capital, disappointing performa...

Edison recently published a note on JPMorgan European Discovery Trust. ************************************************************************************** About ‘Bull, Bear & Beyond’ Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their market...

Edison recently published a note on Baillie Gifford US Growth Trust. ************************************************************************************** About ‘Bull, Bear & Beyond’ Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets...

In this interview, we speak with Ailsa Craig and Marek Poszepczynski, portfolio managers at International Biotechnology Trust (IBT), a UK-based investment company that targets innovative biotech companies which address high unmet medical needs, while offering investors the opportunity for financial returns. ************************************************************************************** Abou...

Edison’s investment companies team recently published a review of The Diverse Income Trust. Managers Gervais Williams and Martin Turner run a UK multi-income strategy aiming to provide an attractive and growing level of dividends, coupled with capital growth over the long term. They are very bullish on the outlook for UK stocks given their attractive valuations and income prospects. Capital growth...

Cordel Group’s CEO John Davis highlights the factors behind the company’s recent commercial success, including new client wins in North and Latin America, the Middle East and the Asia-Pacific region. He also addresses balancing business development with managing an expanding customer base and explains why opportunities to cross-sell additional modules are now opening up. Finally, he outlines finan...

SenSen Networks’ CEO, Subhash Challa, and CFO, Christian Stevens, discuss how the business has transformed over the past 12 months and the factors that have enabled SenSen to deliver strong business momentum on a significantly lower cost base. Subhash explains the specific drivers behind SenSen’s momentum in Canada and why he believes the US market may not be far behind. Christian outlines how Sen...

In this interview, we speak to Dr Christian Koch, deputy head of investment management at BB Biotech (BION), the Switzerland-based investment company listed in Switzerland, Germany and Italy. Dr Koch will assume the role of head of investment management at BB Biotech at the beginning of 2025. ************************************************************************************** About ‘Bull, Bear &...

Edison’s investment companies team recently published a review of the abrdn UK Smaller Companies Growth Trust. Managers Abby Glennie and Amanda Yeaman are encouraged by further improvement in the trust’s performance as the UK stock market is once again rewarding companies with strong fundamentals, while interest rate cuts typically lead to small- and mid-cap share price outperformance versus large...

HBM Healthcare Investments (SIX: HBMN) is a Swiss investment company focused on the global healthcare sector, with a particular focus on private equity and small-cap and emerging biotech companies. In this interview, we talk with the CEO, Dr Andreas Wicki, about the broader healthcare trends, the outlook for the sector and how the company’s portfolio is positioned to leverage the dynamism in the s...

In this interview, James Smith, fund manager of Premier Miton Global Renewables Trust (PMGR), discusses the trust’s portfolio as well as the broader renewable energy sector. PMGR’s investment objectives include achieving a high income and realising long-term growth in capital value. The company invests principally in equity and equity-related securities of companies operating primarily in the rene...

In our interview with Darcy Willson-Rymer, CEO of Card Factory, we discuss the recently released H125 results, the progress the company is making on its ‘Opening Our New Future’ strategy (see our initiation note for more details) and the outlook for the rest of the year. We begin by discussing the growth drivers in retail, including the contribution from the product categories and store expansion....

The London Tunnels owns the Kingsway Exchange Tunnels in Central London and is aiming to develop a major heritage and cultural attraction, targeting full commercial launch in 2027. The company is listed on the Euronext Amsterdam. ************************************************************************************** About ‘Bull, Bear & Beyond’ Bull, Bear & Beyond': features candid conversat...

Medigene (FSE: MDG1) is a publicly listed, Germany-based, immuno-oncology platform company focused on the development of T cell receptor (TCR)-guided therapies with the aim of effectively eliminating cancer. Medigene has a broad and active pipeline focused on a range of modalities. Notably, lead programme MDG1015 is a first-in-class, third-generation T cell receptor-engineered T cell (TCR-T) thera...

AFT Pharmaceuticals (NZX: AFT) is a commercial-stage specialty pharma company with strong roots in Australasia, its own salesforce and a growing global presence through licensing and distribution agreements. The product portfolio is a mix of own-branded, generic and in-licensed products across various therapeutic areas, targeting the over-the-counter, hospital and prescription segments. AFT is pro...

Regional REIT (RGL) is a specialist investor in offices across regional centres of the UK, outside the M25. It is actively managed with a strong focus on income returns. The steep rise in interest rates, combined with uncertainty about the pattern of post-pandemic office use, has seen office values fall significantly. In August, RGL successfully raised more than £100m in new equity, to repay borro...